Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTCN.L Regulatory News (TCN)

  • There is currently no data for TCN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Review, including Formal Sale Process

21 Jul 2021 07:00

RNS Number : 9053F
Tricorn Group PLC
21 July 2021
 

21 July 2021

Tricorn Group PLC

("TCN" or "the Company")

Strategic Review, Formal Sale Process and Commencement of Offer Period

As set out in the Company's interim results published today, as a result of the global pandemic, Tricorn has experienced an extended period of challenging markets and turbulent trading. Significant changes to the senior executive team have been made and customer demand is steadily improving which is a welcome sign that the Company is returning to pre-pandemic levels of production activity.

 

It is anticipated that the impact of COVID-19, the significant incidence of material inflation and the shipping delays of imported material will continue to put pressure on operating costs and margins in the near term. While the Group is currently operating within its borrowing facilities, the near term reduction in profitability and the increased pressure on working capital mean that these facilities alone will not provide the Group with the necessary cash to make the required investment to deliver the turnaround strategy and return the Group to profitable cash generation.

 

In light of these matters, the board of directors ("Board") has now determined to undertake a review of the strategic options open to it in order to maximise value for shareholders. These options include, but are not limited to, a sale of the Company which will be conducted under the framework of a "formal sale process" in accordance with the Takeover Code, or the sale of one or more of the Company's operations.

The Company's largest shareholder, Roger Allsop, Non-Executive Director of TCN, who has a shareholding of approximately 34.23 per cent. of the issued share capital of TCN, has indicated his support for such a strategic review.

The Board has appointed Arden Partners plc ("Arden") as its financial adviser. Parties with a potential interest in making a proposal should contact Arden, whose details are set out below.

Any interested party will be required to enter into a non-disclosure agreement with the Company on terms satisfactory to the Board and its advisers. The Company then intends to provide such interested parties with certain information on the business, following which interested parties will be invited to submit their proposals to Arden. Further announcements regarding timings and procedures for the formal sale process will be made as appropriate. The Company is not currently in any discussions with any potential offeror relating to an acquisition of the issued and to be issued share capital of the Company.

Shareholders are advised that there can be no certainty that any offers will be made, nor as to the terms of any offer, and thus whether any offer will be completed. The Board reserves the right to alter any aspect of the process or to terminate it at any time and will make further announcements as appropriate. The Board also reserves the right to reject any approach or terminate discussions with any interested party or participant at any time.

Rules 2.4(a), 2.4(b) and 2.6(a) of the Takeover Code

The Takeover Panel has granted a dispensation from the requirements of Rules 2.4(a), 2.4(b) and 2.6(a) of the Takeover Code such that any interested party participating in the formal sale process will not be required to be publicly identified as a result of this announcement (subject to Note 3 to Rule 2.2 of the Takeover Code) and will not be subject to the 28 day deadline referred to in Rule 2.6(a), for so long as it is participating in the formal sale process. Interested parties should note Rule 21.2 of the Takeover Code, which will prohibit any form of inducement fee or other offer-related arrangement, and that the Company, although it may do so in the future, has not at this stage requested any dispensation from this prohibition under Note 2 of Rule 21.2.Following this announcement, the Company is now considered to be in an "offer period" as defined in the Takeover Code, and the dealing disclosure requirements summarised below will apply.

This announcement is not an announcement of a firm intention to make an offer under Rule 2.7 of the Takeover Code and there can be no certainty that an offer will be made, nor as to the terms on which any offer will be made.

Enquiries

Tricorn Group plc

Andrew Moss, Chairman

Michael Stock, Chief Executive and Group Finance Director

www.tricorn.uk.com 

+44 (0)7768 306 701

+44 (0)7894 784 106

Arden Partners plc (financial and Rule 3 adviser, nominated adviser and broker)

+44 (0)20 7614 5900

Richard Johnson

Steve Douglas

Oscair McGrath 

Arden is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for the Company and no one else in connection with the matters referred to in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to the customers of Arden or for providing advice in relation to the matters described in this announcement.

Rule 2.9

In accordance with Rule 2.9 of the Code, TCN confirms that it has in issue 49,219,285 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") admitted to trading on the AIM Market of the London Stock Exchange. The International Securities Identification Number for TCN Ordinary Shares is GB0009716340.

Dealing Disclosure Requirements of the City Code on Takeovers and Mergers

Under Rule 8.3(a) of the Takeover Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

MAR

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014, as implemented into English law ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

Publication on Website

A copy of this announcement will be made available at www.tricorn.uk.com no later than 12:00 noon (London time) on 22 July 2021 (being the business day following the date of this announcement) in accordance with Rule 26.1 of the Takeover Code. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

Forward-Looking Statements

This announcement contains statements which are, or may be deemed to be, "forward-looking statements" which are prospective in nature. All statements other than statements of historical fact are forward-looking statements. They are based on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of a date in the future or forward-looking words such as "plans", "expects", "is expected", "is subject to", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes", "targets", "aims", "projects" or words or terms of similar substance or the negative of those terms, as well as variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations or events that are beyond the Company's control.

Forward-looking statements include statements regarding the intentions, beliefs or current expectations of the Company concerning, without limitation, future revenues, economic performance, financial condition, and future prospects.

Such forward-looking statements involve known and unknown risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors may cause the actual results, performance or achievements of TCN to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. 

Neither TCN nor any of its Directors, officers or advisers provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this document will actually occur. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. 

Other than in accordance with its legal or regulatory obligations (including under the AIM Rules and the Disclosure Guidance and Transparency Rules), TCN is not under any obligation and TCN expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

No Offer or Solicitation

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities or the solicitation of any vote or approval in any jurisdiction. Any offer (if made) will be made solely by certain offer documentation which will contain the full terms and conditions of any offer (if made), including details of how such offer may be accepted. This announcement has been prepared in accordance with English law and the Code, and information disclosed may not be the same as that which would have been prepared in accordance with laws outside of the United Kingdom. The release, distribution or publication of this announcement in jurisdictions outside of the United Kingdom may be restricted by laws of the relevant jurisdictions, and therefore persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

Nothing in this announcement is or should be relied on as a promise or representation to the future. This announcement includes certain statements, estimates and projections provided by the Company in relation to the Company's anticipated future performance. Such statements, estimates and projections are based on various assumptions made by the Company concerning anticipated results which may or may not prove to be correct. No representations or warranties are made by any person as to the accuracy of such statements, estimates or projections.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDRMMTTMTATTAB
Date   Source Headline
17th Sep 20215:39 pmRNSTricorn Group PLC
14th Sep 20217:00 amRNSUpdate on USA Payroll Protection Program loan
13th Sep 20217:00 amRNSNotice of Intention to Appoint Administrators
19th Aug 20212:43 pmRNSNotice of Intent and Change of Adviser
18th Aug 20219:30 amRNSStmt re Suspension and End of Formal Sale Process
18th Aug 20217:45 amRNSSuspension - Tricorn Group plc
11th Aug 202111:55 amRNSForm 8.5 (EPT/NON-RI)
10th Aug 20216:33 pmRNSForm 8.3 - Tricorn Group PLC
6th Aug 202111:36 amRNSForm 8.3 - Tricorn Group PLC
3rd Aug 202112:49 pmRNSDion Steward (Form 8.3 - Tricorn Goup plc)
3rd Aug 202112:48 pmRNSForm 8 (OPD) Tricorn Group plc
3rd Aug 202111:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Aug 202111:02 amRNSForm 8.3 - Tricorn Group PLC
2nd Aug 20219:29 amRNSForm 8.3 - Tricorn Group plc
29th Jul 202111:58 amRNSForm 8.5 (EPT/NON-RI)
28th Jul 20217:00 amRNSCompany and Formal Sale Process Update
26th Jul 202112:32 pmRNSForm 8.3 - Tricorn Group plc
23rd Jul 202111:55 amRNSForm 8.5 (EPT/NON-RI)
22nd Jul 202112:03 pmRNSForm 8.5 (EPT/NON-RI)
22nd Jul 202111:59 amGNWForm 8.3 - [Tricorn Group plc - 21 07 2021 Opening Declaration] - (HHL)
21st Jul 20217:00 amRNSStrategic Review, including Formal Sale Process
30th Jun 20219:50 amRNSResult of Adjourned AGM
30th Jun 20217:00 amRNSFinal Results
28th Jun 20217:00 amRNSNotice of Annual Report and Interim Results
21st Jun 202112:41 pmRNSHolding(s) in Company
19th Apr 20217:01 amRNSReceipt of USA Payroll Protection Program loan
19th Apr 20217:00 amRNSChange of Adviser
12th Apr 20217:00 amRNSApproval of USA Payroll Protection Program loan
31st Mar 202111:04 amRNSResult of AGM
31st Mar 20217:00 amRNSUnaudited Preliminary Results
25th Mar 20217:00 amRNSCoronavirus Business Interruption Loan Scheme
19th Mar 202111:27 amRNSHolding(s) in Company
5th Mar 202110:00 amRNSNotice of AGM
25th Feb 20217:00 amRNSRe publication of audited final results
23rd Feb 202110:18 amRNSUpdate on USA Payroll Protection Program loan
29th Jan 20217:00 amRNSFurther Post-Period End and Q1 Trading Update
13th Jan 202111:45 amRNSHolding(s) in Company
11th Jan 20217:01 amRNSFurther Post-Period End Update
11th Jan 20217:00 amRNSDirectorate Changes
17th Dec 20205:44 pmRNSRe Intended Publication of Audited Accounts
7th Dec 20201:22 pmRNSFurther Post-Period End Update
16th Nov 20207:00 amRNSPost-Period End Update
6th Aug 20207:00 amRNSAward of Share Options
23rd Jun 20207:00 amRNSInterim Results
16th Jun 20209:00 amRNSAppointment of Group Finance Director
4th Jun 20207:00 amRNSTrading Update
2nd Apr 20201:05 pmRNSChange of Accounting Reference Date
20th Mar 202012:42 pmRNSCOVID-19 Impact
3rd Mar 20201:09 pmRNSDirectorate Change
25th Feb 20203:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.